Lytell, A. A., and Hewson, K., Proc. Soc. Exp. Biol. and Med., 74, 555 (1950).

Objective: The purpose of the present study was to demonstrate clinical equivalence between the application of collagenase ointment at 24- and 48-hour intervals in the healing of pressure ulcers.

Participants will be randomized into a 1:1:1 ratio to receive EscharEx, placebo or collagenase, which is marketed in the United States as SANTYL and in Europe as IRUXOL. Over a 14-week period ...

EscharEx IND Submission by Year-End; Phase 3 Study to Begin Shortly Thereafter; KOL Event Set for January 8, 2025 FDA Approves NexoBrid for Pediatric Use $25 Million Financing and €16.25 Million ...

Drugs included on the list for exceptional importation and sale are called "designated drugs". They are eligible for exceptional importation and sale as per sections C.10.004 to C.10.011 of the Food ...